Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|
Research & Development Expenses (R&D) | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|
% growth | 4,119.0 0.0% | 4,017.0 (2.5%) | 3,009.0 (25.1%) | 3,502.0 16.4% | 3,628.0 3.6% | 3,721.0 2.6% | 3,773.0 1.4% |
Cost of Goods Sold (COGS) | 2,620.0 | 2,638.0 | 2,101.0 | 2,315.0 | 2,619.0 | 2,809.0 | 2,833.0 |
% margin | 1,499.0 36.4% | 1,379.0 34.3% | 908.0 30.2% | 1,187.0 33.9% | 1,009.0 27.8% | 912.0 24.5% | 940.0 24.9% |
Operating Expenses | 929.0 | 880.0 | 714.0 | 729.0 | 473.0 | 339.0 | 940.0 |
Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative Expenses (SG&A) | 696.0 | 655.0 | 530.0 | 559.0 | 325.0 | 316.0 | 311.0 |
% margin | 570.0 13.8% | 512.0 12.7% | 194.0 6.4% | 458.0 13.1% | 536.0 14.8% | 599.0 16.1% | 302.0 8.0% |
Interest Income | 0.0 | 13.0 | 4.0 | 33.0 | 8.0 | 26.0 | 0.0 |
Interest Expense | 0.0 | 4.0 | 4.0 | 31.0 | 69.0 | 60.0 | 39.0 |
Pre-tax Income | 573.0 | 502.0 | 198.0 | 460.0 | 467.0 | 369.0 | 405.0 |
% effective tax rate | 154.0 26.9% | 125.0 24.9% | 28.0 14.1% | 129.0 28.0% | 131.0 28.1% | 116.0 31.4% | 103.0 25.4% |
% margin | 419.0 10.2% | 377.0 9.4% | 170.0 5.6% | 331.0 9.5% | 336.0 9.3% | 253.0 6.8% | 302.0 8.0% |
EPS | 9.47 | 8.55 | 3.85 | 7.52 | 7.65 | 6.02 | 7.35 |
Diluted EPS | 9.47 | 8.55 | 3.85 | 7.52 | 7.57 | 5.93 | 7.19 |
% margin | 768.0 18.6% | 691.0 17.2% | 352.0 11.7% | 468.0 13.4% | 645.0 17.8% | 576.0 15.5% | 302.0 8.0% |
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
As of today, Sylvamo Corporation's last 12-month Research & Development Expenses (R&D) is $0.0, based on the financial report for Dec 31, 2024 (Q4’2024).
Over the last year, Sylvamo Corporation's Research & Development Expenses (R&D) growth was N/A. The average annual Research & Development Expenses (R&D) growth rates for Sylvamo Corporation have been N/A over the past three years, N/A over the past five years.